Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

100%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(100.0%)
3Total
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04669015Phase 3Unknown

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Role: lead

NCT05172037Phase 3Unknown

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Role: lead

NCT04708158Phase 3Unknown

Novaferon for COVID-19 Treatment Trial (NCTT-005)

Role: lead

All 3 trials loaded